OSCR Oscar Health, Inc. Class A Common Stock

NYSE · Insurance · Auf SEC EDGAR ansehen ↗
$31,51
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 7, 2026

Über Oscar Health, Inc. Class A Common Stock Unternehmensübersicht von Wikipedia

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

Mehr lesen

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

History

2012–2015

According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Joshua and his brother Jared owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.

2016

Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".

In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."

2017

On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.

On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.

A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Joshua's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.

While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.

2020–present

In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."

As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."

Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.

Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.

Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO. [1]

In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.

Marketing and brand

Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".

In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.

In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.

Finances

Funding

Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.

During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.

During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.

In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.

During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.

In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.

Revenue

In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.

Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."

By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.

In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.

In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.

In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.

In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.

Headquarters and offices

Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.

Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗

Wikidata ↗

OSCR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$31.51
Marktkapitalisierung
P/E (TTM)
-8.5
EPS (TTM)
$-1.69
Umsatz (TTM)
$11.70B
Dividendenrendite
ROE
-44.5%
Verschuldungsgrad
0.4
52W-Spanne
$11 – $33

OSCR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $11.70B
7-point trend, +2296.9%
2019-12-31 2025-12-31
EPS $-1.69
7-point trend, +81.3%
2019-12-31 2025-12-31
Freier Cashflow $1.06B
4-point trend, +609.8%
2021-12-31 2025-12-31
Margen -3.8%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
OSCR
Peer-Median
P/E (TTM)
5-point trend, -246.6%
-8.5
13.5

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
OSCR
Peer-Median
Operating Margin (Betriebsgewinnmarge)
4-point trend, +88.6%
-3.4%
Net Profit Margin (Nettogewinnmarge)
4-point trend, +87.8%
-3.8%
5.4%
ROA
4-point trend, +61.2%
-7.9%
0.55%
ROE
4-point trend, -21.3%
-44.5%
8.0%
ROIC
4-point trend, +27.4%
-28.5%

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
OSCR
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
4-point trend, +0.44
0.4
Current Ratio (Liquiditätsgrad)
4-point trend, -23.8%
0.9
0.1
Quick Ratio
4-point trend, -4.3%
0.6

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
OSCR
Peer-Median
Revenue YoY (Umsatz YoY)
5-point trend, +536.4%
27.5%
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, +536.4%
43.5%
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, +536.4%
90.8%

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
OSCR
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, +47.2%
$-1.69

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
OSCR
Peer-Median

OSCR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 19 Analysten
  • Starker Kauf 2 10,5%
  • Kauf 7 36,8%
  • Halten 9 47,4%
  • Verkauf 1 5,3%
  • Starker Verkauf 0 0,0%

12-Monats-Kursziel

10 Analysten · 2026-08-15
Median-Ziel $28.50 -9,6%
Mittelwert-Ziel $29.00 -8,0%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
0.16%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $1.10 $0.39 0.71%
31. März 2026 $2.07 $1.21 0.86%
31. Dezember 2025 $-1.24 $-0.91 -0.33%
30. September 2025 $-0.53 $-0.57 0.04%
30. Juni 2025 $-0.89 $-0.47 -0.42%
31. März 2025 $0.92 $0.81 0.11%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
OSCR -8.5 27.5% -3.8% -44.5%
PRU
PFG $19.18B 16.8 -3.1% 7.6% 10.3%
UNM
GL $12.90B 9.9 3.7% 19.4% 20.4%
PRI $8.22B 11.3 6.6% 22.8% 31.9%
LNC $8.46B 7.6 -1.2% 6.5% 12.3%
CNO $4.01B 18.5 0.85% 5.1% 8.9%
GNW $3.54B 16.7 0.08% 3.0% 2.6%

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 13
Jährliche Gewinn- und Verlustrechnung-Daten für OSCR
Kennzahl Trend 202520242023202220212020
Revenue 6-point trend, +2428.4% $11.70B $9.18B $5.86B $3.96B $1.84B $463M
SG&A Expense 6-point trend, +1130.0% $2.05B $1.76B $1.43B $1.26B $265M $167M
Operating Income 6-point trend, +1.5% $-396M $57M $-236M $-590M $-544M $-402M
Interest Expense 4-point trend, +600.1% · · $25M $23M $5M $4M
Other Non-op 5-point trend, -1843.3% $-23M $-105.0K $-7M $2M $-1M ·
Pretax Income 6-point trend, -7.8% $-437M $33M $-267M $-610M $-571M $-406M
Income Tax 6-point trend, +436.5% $6M $7M $3M $-523.0K $846.0K $1M
Net Income 6-point trend, -8.9% $-443M $25M $-271M $-606M $-573M $-407M
EPS (Basic) 6-point trend, +88.1% $-1.69 $0.11 $-1.22 $-2.85 $-3.20 $-14.16
EPS (Diluted) 6-point trend, +88.1% $-1.69 $0.10 $-1.22 $-2.85 $-3.20 $-14.16
Shares (Basic) 6-point trend, +796.6% 262,388,000 240,386,000 221,655,000 212,475,000 178,967,056 29,263,424
Shares (Diluted) 6-point trend, +796.6% 262,388,000 265,853,000 221,655,000 212,475,000 178,967,056 29,263,424
EBITDA 4-point trend, +30.7% $-367M $89M $-205M · $-530M ·
Bilanz 23
Jährliche Bilanz-Daten für OSCR
Kennzahl Trend 202520242023202220212020
Cash & Equivalents 6-point trend, +235.7% $2.77B $1.53B $1.87B $1.56B $1.10B $826M
Short-term Investments 2-point trend, -9.5% · $624M $690M · · ·
Receivables $363M · · · · ·
Other Current Assets 5-point trend, +543.3% $24M $21M $7M $6M $4M ·
Current Assets 6-point trend, +146.6% $4.61B $2.85B $3.06B $4.12B $2.31B $1.87B
PP&E (Net) 6-point trend, +146.7% $88M $67M $62M $60M $47M $36M
PP&E (Gross) 6-point trend, +263.3% $230M $181M $150M $117M $89M $63M
Accum. Depreciation 6-point trend, +415.1% $142M $114M $88M $57M $42M $27M
Other Non-current Assets 6-point trend, +811.4% $120M $82M $83M $95M $97M $13M
Total Assets 6-point trend, +178.4% $6.33B $4.84B $3.60B $4.53B $3.32B $2.27B
Accounts Payable 6-point trend, +268.9% $507M $432M $273M $298M $235M $138M
Current Liabilities 6-point trend, +191.9% $4.86B $3.46B $2.43B $3.26B $1.85B $1.67B
Capital Leases 5-point trend, -32.3% $52M $61M $67M $72M $77M ·
Other Non-current Liabilities 6-point trend, +51994000.00 $52M $61M $68M $72M $77M $0
Total Liabilities 6-point trend, +193.2% $5.34B $3.82B $2.80B $3.63B $1.93B $1.82B
Total Debt 4-point trend, +430095000.00 $430M $300M $299M · $0 ·
Common Stock · · · · · $2.0K
Paid-in Capital 6-point trend, +3094.6% $4.26B $3.87B $3.68B $3.51B $3.39B $133M
Retained Earnings 6-point trend, -130.8% $-3.29B $-2.85B $-2.88B $-2.61B $-2.00B $-1.43B
Treasury Stock Flat — no change across 6 periods $3M $3M $3M $3M $3M $3M
AOCI 6-point trend, +1951.2% $18M $-2M $1M $-10M $-4M $879.0K
Stockholders' Equity 6-point trend, +175.4% $978M $1.01B $804M $890M $1.39B $-1.30B
Liabilities + Equity 6-point trend, +178.4% $6.33B $4.84B $3.60B $4.53B $3.32B $2.27B
Cashflow 16
Jährliche Cashflow-Daten für OSCR
Kennzahl Trend 202520242023202220212020
D&A 6-point trend, +156.0% $29M $32M $31M $15M $15M $11M
Stock-based Comp 6-point trend, +144.4% $88M $110M $160M $112M $86M $36M
Deferred Tax 6-point trend, +3755.2% $2M $-2M $58.0K $-165.0K $-101.0K $-67.0K
Other Non-cash 4-point trend, +389.2% $1.42B $813M $-192M · $290M ·
Operating Cash Flow 6-point trend, +391.6% $1.09B $978M $-272M $380M $-182M $223M
CapEx 6-point trend, +159.4% $36M $28M $26M $29M $26M $14M
Investing Cash Flow 6-point trend, +30.1% $-241M $-1.39B $577M $-227M $-775M $-345M
Debt Issued 6-point trend, +178.9% $410M $0 $0 $305M $0 $147M
Net Debt Issued 3-point trend, +410000000.00 $410M $0 $0 · · ·
Stock Repurchased Flat — no change across 2 periods · · · · $0 $0
Net Stock Activity · · · · $0 ·
Financing Cash Flow 6-point trend, -34.7% $399M $68M $6M $301M $1.24B $612M
Net Change in Cash 6-point trend, +155.9% $1.25B $-341M $311M $455M $282M $490M
Taxes Paid 6-point trend, +1048.6% $18M $674.0K $2M $2M $697.0K $2M
Free Cash Flow 4-point trend, +609.8% $1.06B $950M $-298M · $-208M ·
Levered FCF 2-point trend, -51.9% · · $-323M · $-212M ·
Rentabilität 7
Jährliche Rentabilität-Daten für OSCR
Kennzahl Trend 202520242023202220212020
Operating Margin 4-point trend, +88.6% -3.4% 0.62% -4.0% · -29.6% ·
Net Margin 4-point trend, +87.8% -3.8% 0.28% -4.6% · -31.1% ·
Pretax Margin 4-point trend, +87.9% -3.7% 0.36% -4.6% · -31.0% ·
EBITDA Margin 4-point trend, +89.1% -3.1% 0.97% -3.5% · -28.8% ·
ROA 4-point trend, +61.2% -7.9% 0.60% -6.7% · -20.5% ·
ROE 4-point trend, -21.3% -44.5% 2.8% -32.0% · -36.7% ·
ROIC 4-point trend, +27.4% -28.5% 3.4% -21.6% · -39.3% ·
Liquidität & Solvenz 5
Jährliche Liquidität & Solvenz-Daten für OSCR
Kennzahl Trend 202520242023202220212020
Current Ratio 4-point trend, -23.8% 0.9 0.8 1.3 · 1.2 ·
Quick Ratio 4-point trend, -4.3% 0.6 0.6 0.8 · 0.6 ·
Debt / Equity 4-point trend, +0.44 0.4 0.3 0.4 · 0.0 ·
LT Debt / Equity 4-point trend, +0.44 0.4 0.3 0.4 · 0.0 ·
Interest Coverage 2-point trend, +91.7% · · -9.6 · -115.4 ·
Effizienz 1
Jährliche Effizienz-Daten für OSCR
Kennzahl Trend 202520242023202220212020
Asset Turnover 4-point trend, +218.8% 2.1 2.2 1.4 · 0.7 ·
Pro Aktie 3
Jährliche Pro Aktie-Daten für OSCR
Kennzahl Trend 202520242023202220212020
Revenue / Share 4-point trend, +334.1% $44.60 $34.52 $26.45 · $10.27 ·
Cash Flow / Share 4-point trend, +510.9% $4.17 $3.68 $-1.23 · $-1.02 ·
EPS (TTM) 5-point trend, +47.2% $-1.69 $0.10 $-1.22 $-2.85 $-3.20 ·
Wachstumsraten 3
Jährliche Wachstumsraten-Daten für OSCR
Kennzahl Trend 202520242023202220212020
Revenue YoY 5-point trend, -90.8% 27.5% 56.5% 47.9% 115.6% 297.3% ·
Revenue CAGR 3Y 3-point trend, -67.4% 43.5% 70.9% 133.1% · · ·
Revenue CAGR 5Y 90.8% · · · · ·
Bewertung (TTM) 4
Jährliche Bewertung (TTM)-Daten für OSCR
Kennzahl Trend 202520242023202220212020
Revenue TTM 5-point trend, +536.4% $11.70B $9.18B $5.86B $3.96B $1.84B ·
Net Income TTM 5-point trend, +22.6% $-443M $25M $-271M $-606M $-573M ·
P/E 5-point trend, -246.6% -8.5 134.4 -7.5 -0.9 -2.5 ·
Earnings Yield 5-point trend, +71.1% -11.8% 0.74% -13.3% -115.9% -40.8% ·

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $11.70B$9.18B$5.86B$3.96B$1.84B
Betriebsgewinnmarge % -3.4%0.62%-4.0%-29.6%
Nettoergebnis $-443M$25M$-271M$-606M$-573M
Verwässerte EPS $-1.69$0.10$-1.22$-2.85$-3.20
Bilanz
2025-12-312024-12-312023-12-312022-12-312021-12-31
Fremdkapital / Eigenkapital 0.40.30.40.0
Liquiditätsgrad 0.90.81.31.2
Quick Ratio 0.60.60.80.6
Cashflow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Freier Cashflow $1.06B$950M$-298M$-208M

Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 462 Einreicher · $4.5B gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
133 (+65 vs. Vorquartal) 45 (-20 vs. Vorquartal) 140 (+17 vs. Vorquartal) 107 (-3 vs. Vorquartal) +39.9M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
VANGUARD PORTFOLIO MANAGEMENT LLC $314.559.172 11.029.424 7,02% Aktien
VANGUARD CAPITAL MANAGEMENT LLC $301.725.543 10.579.437 6,73% Aktien
D. E. Shaw & Co., Inc. $259.880.743 9.112.228 5,80% Aktien
AMERICAN CENTURY COMPANIES INC $258.255.502 9.055.242 5,76% Aktien
Thrive Capital Management, LLC $180.919.957 6.343.617 4,04% Aktien
STATE STREET CORP $165.454.531 5.801.351 3,69% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $162.917.648 5.712.400 3,64% Kaufoption
GEODE CAPITAL MANAGEMENT, LLC $141.980.956 4.977.203 3,17% Aktien
FMR LLC $138.622.458 4.860.535 3,09% Aktien
TWO SIGMA INVESTMENTS, LP $115.097.850 4.035.689 2,57% Aktien
BIT Capital GmbH $97.480.134 3.417.957 2,18% Aktien
DIMENSIONAL FUND ADVISORS LP $94.434.740 3.311.177 2,11% Aktien
RENAISSANCE TECHNOLOGIES LLC $93.673.940 3.284.500 2,09% Aktien
JACOBS LEVY EQUITY MANAGEMENT, INC $86.282.012 3.025.316 1,93% Aktien
JANE STREET GROUP, LLC $74.631.792 2.616.823 1,67% Aktien
GLYNN CAPITAL MANAGEMENT LLC $73.462.615 2.575.828 1,64% Aktien
CITADEL ADVISORS LLC $72.469.320 2.541.000 1,62% Kaufoption
WOLVERINE ASSET MANAGEMENT LLC $61.825.656 2.167.800 1,38% Verkaufsoption
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60.458.493 2.119.863 1,35% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $55.351.616 1.940.800 1,24% Verkaufsoption
JANE STREET GROUP, LLC $53.968.396 1.892.300 1,20% Kaufoption
BlackBarn Capital Partners LP $49.910.000 1.750.000 1,11% Verkaufsoption
BNP PARIBAS FINANCIAL MARKETS $48.660.710 1.706.196 1,09% Aktien
VANGUARD FIDUCIARY TRUST CO $45.996.029 1.612.764 1,03% Aktien
CITADEL ADVISORS LLC $44.459.828 1.558.900 0,99% Verkaufsoption
STATE OF MICHIGAN RETIREMENT SYSTEM $41.354.000 1.450.000 0,92% Aktien
BANK OF AMERICA CORP /DE/ $36.176.793 1.268.471 0,81% Aktien
Assenagon Asset Management S.A. $35.592.732 1.247.992 0,79% Aktien
TWO SIGMA ADVISERS, LP $35.534.136 2.472.800 0,79% Aktien
JANE STREET GROUP, LLC $33.796.200 1.185.000 0,75% Verkaufsoption
GROUP ONE TRADING LLC $32.744.154 1.148.112 0,73% Aktien
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $31.200.652 1.093.992 0,70% Aktien
Qube Research & Technologies Ltd $30.913.940 1.083.939 0,69% Aktien
TUDOR INVESTMENT CORP ET AL $29.055.948 1.018.792 0,65% Aktien
GILDER GAGNON HOWE & CO LLC $28.576.515 1.001.982 0,64% Aktien
GOLDMAN SACHS GROUP INC $26.322.819 922.960 0,59% Aktien
Walleye Capital LLC $23.243.058 814.974 0,52% Aktien
Point72 Asset Management, L.P. $22.809.212 799.762 0,51% Aktien
Walleye Trading LLC $22.744.700 797.500 0,51% Kaufoption
FEDERATED HERMES, INC. $22.241.550 779.858 0,50% Aktien
Walleye Trading LLC $20.594.292 722.100 0,46% Verkaufsoption
Balyasny Asset Management L.P. $20.211.240 708.669 0,45% Aktien
WOLVERINE TRADING, LLC $19.244.780 1.006.000 0,43% Kaufoption
MILLENNIUM MANAGEMENT LLC $18.292.101 641.378 0,41% Aktien
Halter Ferguson Financial Inc. $17.882.240 627.007 0,40% Aktien
CITADEL ADVISORS LLC $17.044.921 597.648 0,38% Aktien
Walleye Trading LLC $15.952.833 559.356 0,36% Aktien
Caption Management, LLC $15.723.076 551.300 0,35% Verkaufsoption
WOLVERINE TRADING, LLC $14.846.793 776.100 0,33% Verkaufsoption
CAPITAL FUND MANAGEMENT S.A. $14.807.327 519.191 0,33% Aktien
PFM Health Sciences, LP $14.802.336 519.016 0,33% Aktien
CANADA PENSION PLAN INVESTMENT BOARD $14.317.040 502.000 0,32% Aktien
WELLS FARGO & COMPANY/MN $14.301.981 501.472 0,32% Aktien
Eurizon Capital SGR S.p.A. $13.987.854 490.380 0,31% Aktien
RPG Investment Advisory, LLC $13.981.017 490.218 0,31% Aktien
TUDOR INVESTMENT CORP ET AL $13.977.652 490.100 0,31% Kaufoption
Caption Management, LLC $13.769.456 482.800 0,31% Kaufoption
Alphabet Inc. $13.746.298 481.988 0,31% Aktien
Swiss National Bank $13.501.368 473.400 0,30% Aktien
CREDIT AGRICOLE S A $13.119.286 460.003 0,29% Aktien
RBF Capital, LLC $12.822.706 449.604 0,29% Aktien
MILLENNIUM MANAGEMENT LLC $12.802.628 448.900 0,29% Verkaufsoption
Trexquant Investment LP $12.674.259 444.399 0,28% Aktien
BlackRock, Inc. $12.343.114 432.788 0,28% Aktien
IMC-Chicago, LLC $12.036.581 422.040 0,27% Aktien
FORA Capital, LLC $11.957.021 419.030 0,27% Aktien
PERCEPTIVE ADVISORS LLC $11.408.000 400.000 0,25% Aktien
Connor, Clark & Lunn Investment Management Ltd. $11.327.203 397.167 0,25% Aktien
Rhenman & Partners Asset Management AB $11.179.840 392.000 0,25% Aktien
SILVERCREST ASSET MANAGEMENT GROUP LLC $10.799.925 378.679 0,24% Aktien
UBS Group AG $10.607.358 371.927 0,24% Aktien
WELLINGTON MANAGEMENT GROUP LLP $10.027.661 351.601 0,22% Aktien
ARDSLEY ADVISORY PARTNERS LP $9.982.000 350.000 0,22% Aktien
VICTORY CAPITAL MANAGEMENT INC $9.924.475 347.983 0,22% Aktien
Fiduciary Alliance LLC $9.802.210 343.696 0,22% Aktien
BCS Private Wealth Management, Inc. $9.665.000 338.885 0,22% Aktien
SIMPLEX TRADING, LLC $9.283.516 325.509 0,21% Aktien
Squarepoint Ops LLC $9.166.214 321.396 0,20% Aktien
SEB Asset Management AB $9.085.456 318.565 0,20% Aktien
MARSHALL WACE, LLP $9.052.762 317.418 0,20% Aktien
Squarepoint Ops LLC $8.906.796 312.300 0,20% Kaufoption
BARCLAYS PLC $8.827.711 309.527 0,20% Aktien
Engineers Gate Manager LP $8.802.185 308.632 0,20% Aktien
TOWLE & CO $8.801.186 308.597 0,20% Aktien
RHUMBLINE ADVISERS $8.563.598 300.267 0,19% Aktien
PRUDENTIAL FINANCIAL INC $8.412.544 294.970 0,19% Aktien
FIRST TRUST ADVISORS LP $8.152.727 285.860 0,18% Aktien
MILLENNIUM MANAGEMENT LLC $7.939.968 278.400 0,18% Kaufoption
FRED ALGER MANAGEMENT, LLC $7.777.290 272.696 0,17% Aktien
TORONTO DOMINION BANK $7.632.066 267.604 0,17% Aktien
BANK OF MONTREAL /CAN/ $7.383.828 258.900 0,16% Verkaufsoption
General Equity Holdings LP $6.844.800 240.000 0,15% Aktien
TD Asset Management Inc $6.561.311 230.060 0,15% Aktien
VANGUARD ASSET MANAGEMENT, Ltd $6.509.690 228.250 0,15% Aktien
OSAIC HOLDINGS, INC. $6.398.318 224.346 0,14% Aktien
AMERIPRISE FINANCIAL INC $6.363.383 223.120 0,14% Aktien
Squarepoint Ops LLC $6.203.100 217.500 0,14% Verkaufsoption
Public Sector Pension Investment Board $6.120.392 214.600 0,14% Aktien
Bridgewater Associates, LP $6.094.838 213.704 0,14% Aktien
NORGES BANK $5.741.390 201.311 0,13% Aktien

Unternehmensinsider 21 Insider · 10 Führungskräfte · 12 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Mark T Bertolini Chief Executive Officer 30. Juni 2026 S 7.751.570 1 8 $-58.759.399
Richard Scott Blackley Chief Financial Officer 2. Juni 2026 S 1.074.977 0 1 $-493.628
Janet Liang President, Oscar Insurance 2. Juni 2026 S 259.057 0 1 $-194.356
Meghan V. Joyce Chief Operating Officer 1. September 2021 M 34.669 0 0 $0
Victoria Baltrus Chief Accounting Officer 2. Juni 2026 S 214.589 0 1 $-23.718
Adam Mcananey Chief Legal Officer 2. Juni 2026 S 218.096 0 1 $-153.593
Joshua Kushner Co-Founder and Vice Chairman 21. November 2024 P 6.343.617 0 0 $0
Dennis Weaver Chief Clinical Officer 1. September 2021 M 5.323 0 0 $0
Alessandrea C. Quane EVP, Chief Insurance Officer 31. August 2021 A 0 0 $0
Joel Klein Chief Policy & Strat. Officer 5. März 2021 A 0 0 0 $0
William Gassen Direktor 9. Juli 2026 A 82.840 0 0 $0
David Plouffe Direktor 9. Juli 2026 A 137.121 0 0 $0
Sid Sankaran Direktor 9. Juli 2026 A 22.609 0 0 $0
Mario Schlosser Direktor 1. Juli 2026 C 0 0 16 $-32.199.014
Laura W Lang Direktor 4. Juni 2026 A 82.840 0 0 $0
Vanessa Ames Wittman Direktor 4. Juni 2026 A 137.121 0 0 $0
Jeffery H Boyd Direktor 9. April 2026 A 0 0 $0
Elbert O. Robinson Jr. Direktor 5. März 2021 A 50.000 0 0 $0
Teri List-Stoll Direktor 5. März 2021 A 50.000 0 0 $0
Jr Charles E Phillips Direktor 5. März 2021 A 50.000 0 0 $0
Ari Fischel 5. März 2021 A 0 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 1 Beteiligung

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 Einreichungen 13. November 2024 Erste Einreichung SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 65 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
HEAL · Global X Funds 4,61% 51.902 NS 31. Mai 2026 N-PORT
ABLS · Abacus FCF ETF Trust 3,73% 2.476 NS 30. April 2026 N-PORT
CBLS · Elevation Series Trust 2,79% 80.448 NS 30. April 2026 N-PORT
CBSE · Elevation Series Trust 2,79% 72.369 NS 30. April 2026 N-PORT
PTH · Invesco Exchange-Traded Fund Trust 1,80% 159.618 SH 8. August 2026 Täglich
RNIN · EA Series Trust 1,77% 146.523 NS 30. April 2026 N-PORT
IAK · iShares Trust 0,63% 132.150 SH 8. August 2026 Täglich
AVUV · AMERICAN CENTURY ETF TRUST 0,53% 6.454.468 NS 31. Mai 2026 N-PORT
CLSE · Trust for Professional Managers 0,48% 132.126 NS 31. Mai 2026 N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS 0,40% 258.034 SH 8. August 2026 Täglich
IWO · iShares Trust 0,40% 2.189.278 SH 8. August 2026 Täglich
DWAS · Invesco Exchange-Traded Fund Trust … 0,37% 59.569 SH 8. August 2026 Täglich
OASC · Unified Series Trust 0,25% 9.324 NS 31. Mai 2026 N-PORT
DFVE · DoubleLine ETF Trust 0,22% 5.265 NS 31. März 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,21% 1.387.125 SH 8. August 2026 Täglich
IWM · iShares Trust 0,20% 6.138.237 SH 8. August 2026 Täglich
VBK · VANGUARD INDEX FUNDS 0,19% 3.171.535 SH 8. August 2026 Täglich
ISCG · iShares Trust 0,19% 70.748 SH 8. August 2026 Täglich
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,19% 74.299 NS 30. April 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,18% 7.801 NS 30. April 2026 N-PORT
SMLF · iShares Trust 0,18% 282.874 SH 8. August 2026 Täglich
FYC · First Trust Exchange-Traded AlphaDE… 0,18% 99.887 NS 30. April 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,15% 154.382 SH 8. August 2026 Täglich
RSSL · Global X Funds 0,11% 87.779 NS 30. April 2026 N-PORT
ITWO · ProShares Trust 0,11% 9.555 NS 31. Mai 2026 N-PORT
DFAS · Dimensional ETF Trust 0,11% 798.894 NS 30. April 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,10% 1.045.927 NS 31. Mai 2026 N-PORT
AVLV · AMERICAN CENTURY ETF TRUST 0,10% 576.130 NS 31. Mai 2026 N-PORT
ISCB · iShares Trust 0,09% 10.063 SH 8. August 2026 Täglich
FYX · First Trust Exchange-Traded AlphaDE… 0,09% 60.366 NS 30. April 2026 N-PORT
ESML · iShares Trust 0,09% 96.699 SH 8. August 2026 Täglich
VB · VANGUARD INDEX FUNDS 0,08% 5.488.922 SH 8. August 2026 Täglich
VFH · VANGUARD WORLD FUND 0,08% 384.466 SH 8. August 2026 Täglich
VXF · VANGUARD INDEX FUNDS 0,07% 2.534.194 SH 8. August 2026 Täglich
UWM · ProShares Trust 0,07% 7.474 NS 31. Mai 2026 N-PORT
WSML · iShares Trust 0,06% 14.478 SH 8. August 2026 Täglich
URTY · ProShares Trust 0,05% 7.563 NS 31. Mai 2026 N-PORT
AVUQ · AMERICAN CENTURY ETF TRUST 0,05% 5.330 NS 31. Mai 2026 N-PORT
FNCL · FIDELITY COVINGTON TRUST 0,04% 52.605 NS 30. April 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 0,04% 169 NS 31. Mai 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,04% 9.312 NS 30. April 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0,04% 12.030 SH 8. August 2026 Täglich
TILT · FlexShares Trust 0,03% 38.192 NS 30. April 2026 N-PORT
AVMV · AMERICAN CENTURY ETF TRUST 0,03% 8.235 NS 31. Mai 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,03% 164.245 NS 31. Mai 2026 N-PORT
FNDA · SCHWAB STRATEGIC TRUST 0,03% 103.995 NS 31. Mai 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,02% 7.591 NS 31. Mai 2026 N-PORT
HDG · ProShares Trust 0,02% 190 NS 31. Mai 2026 N-PORT
DFAC · Dimensional ETF Trust 0,02% 416.676 NS 30. April 2026 N-PORT
DFSU · Dimensional ETF Trust 0,02% 18.514 NS 30. April 2026 N-PORT